Stage IIIA Non-Small Cell Lung Cancer

Showing 1 - 25 of 71

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Stage IIIB(N2) NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Beijing (Pembrolizumab 200 mg IV infusion)

Not yet recruiting
  • Stage IIIB(N2) Non-small Cell Lung Cancer
  • +3 more
  • Pembrolizumab 200 mg IV infusion
  • Beijing, Beijing, China
    Peking University
May 30, 2023

Stage IIIA NSCLC Trial in Cleveland (Cisplatin, Etoposide, Pembrolizumab)

Terminated
  • Stage IIIA Non-Small Cell Lung Cancer
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Dec 15, 2022

Stage IIIA NSCLC, Stage IIIB NSCLC Trial in United States (drug, procedure, radiation)

Recruiting
  • Stage IIIA Non-small Cell Lung Cancer
  • Stage IIIB Non-small Cell Lung Cancer
  • San Diego, California
  • +14 more
Dec 5, 2022

Non-Squamous Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage IA Non-Small Cell Lung Carcinoma Trial in Abington,

Active, not recruiting
  • Non-Squamous Non-Small Cell Lung Carcinoma
  • +7 more
  • Nivolumab
  • +3 more
  • Abington, Pennsylvania
  • +1 more
Sep 14, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +15 more
  • Los Angeles, California
  • +1 more
Aug 5, 2022

Recurrent NSCLC, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Buffalo (therapeutic lymphadenectomy (TEMLA) and Stereotactic Body

Completed
  • Recurrent Non-small Cell Lung Cancer
  • +3 more
  • therapeutic lymphadenectomy (TEMLA) and Stereotactic Body radiation therapy (SBRT)
  • quality-of-life assessment
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Extensive Stage Small Cell Lung Carcinoma, Lung Adenocarcinoma, Recurrent Non-Small Cell Lung Carcinoma Trial in Scottsdale,

Recruiting
  • Extensive Stage Small Cell Lung Carcinoma
  • +7 more
  • Scottsdale, Arizona
  • +1 more
Jun 27, 2022

Pathological Response After Neoadjuvant Treatment on NSCLC

Recruiting
  • Stage IIIA Non-small Cell Lung Cancer
  • Badalona, Barcelona, Spain
  • +16 more
Jun 1, 2022

Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Detroit (drug, device, other, procedure)

Recruiting
  • Recurrent Non-Small Cell Lung Carcinoma
  • +3 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Mar 30, 2022

Solid Tumor, Stage III Pancreatic Cancer, Stage IIIA Breast Cancer Trial in Atlanta (Carboplatin, Cisplatin, Palbociclib)

Active, not recruiting
  • Solid Neoplasm
  • +16 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Feb 28, 2022

Adenocarcinoma of the Lung, Extensive Stage Small Cell Lung Cancer, Limited Stage Small Cell Lung Cancer Trial in Aurora

Completed
  • Adenocarcinoma of the Lung
  • +7 more
  • Aurora, Colorado
    University of Colorado Cancer Center
Jan 19, 2022

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

Metastatic Malignant Tumor in the Brain, Recurrent Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma Trial

Completed
  • Metastatic Malignant Neoplasm in the Brain
  • +6 more
  • Bronx, New York
  • +1 more
Jan 20, 2022

Febrile Neutropenia, Stage 0 Breast Cancer, Stage 0 Colorectal Cancer Trial in Puerto Rico, United States (Preventive

Completed
  • Febrile Neutropenia
  • +27 more
  • Preventive Intervention
  • +2 more
  • Jonesboro, Arkansas
  • +159 more
Dec 22, 2021

Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Large Cell Lung Cancer Trial in Los Angeles (radiation, other, drug)

Active, not recruiting
  • Adenocarcinoma of the Lung
  • +8 more
  • hypofractionated radiation therapy
  • +5 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Dec 2, 2021

Recurrent Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage II NSCLC Trial in United States (TG4010, Nivolumab)

Completed
  • Recurrent Non-Small Cell Lung Carcinoma
  • +5 more
  • TG4010
  • Nivolumab
  • Duarte, California
  • +3 more
Oct 11, 2021

Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Sacramento (Afatinib Dimaleate,

Completed
  • Recurrent Non-Small Cell Lung Carcinoma
  • +3 more
  • Afatinib Dimaleate
  • Pembrolizumab
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Sep 29, 2021

Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell

Active, not recruiting
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +29 more
  • Cytology specimen
  • Laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 31, 2021

Stage IIIA NSCLC, Stage IIIB NSCLC, Stage IV NSCLC Trial in Los Angeles (Laboratory Biomarker Analysis, Pembrolizumab)

Completed
  • Stage IIIA Non-Small Cell Lung Cancer
  • +2 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jun 24, 2021

Stage IIIA NSCLC Trial in Philadelphia (radiation, drug, procedure)

Completed
  • Stage IIIA Non-small Cell Lung Cancer
  • proton beam radiation therapy
  • +3 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Apr 23, 2021

Recurrent NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Columbus (radiation, drug, other)

Unknown status
  • Recurrent Non-small Cell Lung Cancer
  • +4 more
  • hypofractionated radiation therapy
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 24, 2020

Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer Trial in United States (dietary

Completed
  • Adenocarcinoma of the Lung
  • +7 more
  • soy isoflavones
  • +4 more
  • Bay City, Michigan
  • +4 more
Nov 19, 2020

Recurrent Non-Small Cell Lung Carcinoma, Stage III NSCLC, Stage IIIA NSCLC Trial in Chicago, Lake Forest (other, drug,

Active, not recruiting
  • Recurrent Non-Small Cell Lung Carcinoma
  • +4 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Chicago, Illinois
  • +1 more
Sep 20, 2020

Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Bronx, New York (drug, procedure, other)

Terminated
  • Stage IIIA Non-Small Cell Lung Cancer
  • Stage IIIB Non-Small Cell Lung Cancer
  • Erlotinib Hydrochloride
  • +2 more
  • Bronx, New York
  • +2 more
Jun 24, 2020

Recurrent NSCLC, Squamous Cell Lung Cancer, Stage IIIA NSCLC Trial (drug, other, genetic)

Withdrawn
  • Recurrent Non-small Cell Lung Cancer
  • +5 more
  • (no location specified)
Mar 30, 2020